SALARIUS PHARMACEUTICALS INC's ticker is SLRX and the CUSIP is 79400X107. A total of 19 filers reported holding SALARIUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $450,000 | -28.5% | 424,800 | 0.0% | 0.17% | -45.2% |
| Q1 2021 | $629,000 | +91.8% | 424,800 | +17.8% | 0.30% | +17.3% |
| Q4 2020 | $328,000 | +50.5% | 360,556 | +39.6% | 0.26% | +45.3% |
| Q3 2020 | $218,000 | -36.1% | 258,249 | 0.0% | 0.18% | +7.2% |
| Q2 2020 | $341,000 | +63.9% | 258,249 | -15.1% | 0.17% | +30.5% |
| Q1 2020 | $208,000 | – | 304,347 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| X-Square Capital, LLC | 97,258 | $39,000 | 0.02% |
| Kepos Capital LP | 548,054 | $218,000 | 0.02% |
| Virtu Financial LLC | 39,476 | $16,000 | 0.00% |
| Laird Norton Wetherby Wealth Management, LLC | 39,746 | $16,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 16,400 | $7,000 | 0.00% |
| NORTHERN TRUST CORP | 65,022 | $26,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 390,115 | $155,000 | 0.00% |
| STATE STREET CORP | 142,552 | $57,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 20,128 | $8,000 | 0.00% |